Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway:: Consequences on inflammation

被引:84
作者
Decker, P
Singh-Jasuja, H
Haager, S
Kötter, I
Rammensee, HG
机构
[1] Univ Tubingen, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany
[2] Univ Tubingen Hosp, Dept Internal Med Haematol Oncol Immunol & Rheuma, Tubingen, Germany
关键词
D O I
10.4049/jimmunol.174.6.3326
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nucleosome is the major autoantigen in systemic lupus erythematosus. It is found as a circulating complex in the sera of patients and seems to play a key role in disease development. In this study, we show for the first time that physiologic concentrations of purified nucleosomes directly induce in vitro dendritic cell (DC) maturation of mouse bone marrow-derived DC, human monocyte-derived DC (MDDC), and purified human myeloid DC as observed by stimulation of allogenic cells in MLR, cytokine secretion, and CD86 up-regulation. Importantly, nucleosomes act as free complexes without the need for immune complex formation or for the presence of unmethylated CpG DNA motifs, and we thus identified a new mechanism of DC activation by nucleosomes. We have clearly demonstrated that this activation is nucleosome-specific and endotoxin-independent. Particularly, nucleosomes induce MDDC to secrete cytokines known to be detected in high concentrations in the sera of patients. Moreover, activated MDDC secrete IL-8, a neutrophil chemoattractant also detected in patient sera, and thus might favor the inflammation observed in patients. Both normal and lupus MDDC are sensitive to nucleosome-induced activation. Finally, injection of purified nucleosomes to normal mice induces in vivo DC maturation. Altogether, these results strengthen the key role of nucleosomes in systemic lupus erythematosus and might explain how peripheral tolerance is broken in patients.
引用
收藏
页码:3326 / 3334
页数:9
相关论文
共 39 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus - Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity [J].
Amoura, Z ;
Piette, JC ;
Chabre, H ;
Cacoub, P ;
Papo, T ;
Wechsler, B ;
Bach, JF ;
Koutouzov, S .
ARTHRITIS AND RHEUMATISM, 1997, 40 (12) :2217-2225
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]  
Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO
[5]  
2-C
[6]   Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood [J].
Bender, A ;
Sapp, M ;
Schuler, G ;
Steinman, RM ;
Bhardwaj, N .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 196 (02) :121-135
[7]   Disease activity and antinucleosome antibodies in systemic 1upus erythematosus [J].
Benucci, M ;
Gobbi, FL ;
Del Rosso, A ;
Cesaretti, S ;
Niccoli, L ;
Cantini, F .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2003, 32 (01) :42-45
[8]   Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes [J].
Boulé, MW ;
Broughton, C ;
Mackay, F ;
Akira, S ;
Marshak-Rothstein, A ;
Rifkin, IR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (12) :1631-1640
[9]   PRESENCE OF NUCLEOSOME-RESTRICTED ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
CHABRE, H ;
AMOURA, Z ;
PIETTE, JC ;
GODEAU, P ;
BACH, JF ;
KOUTOUZOV, S .
ARTHRITIS AND RHEUMATISM, 1995, 38 (10) :1485-1491
[10]   Identification of a minimal T cell epitope recognized by antinucleosome Th cells in the C-terminal region of histone H4 [J].
Decker, P ;
Le Moal, A ;
Briand, JP ;
Muller, S .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :654-662